‘Historic Action’: FDA Approves First CAR-T Therapy – Regulatory Focus
|
'Historic Action': FDA Approves First CAR–T Therapy
Regulatory Focus In addition to Kymriah's approval, FDA also announced the expanded approval of Roche's Actemra (tocilizumab) to treat CAR T-cell-induced severe or life-threatening cytokine release syndrome in patients 2 years of age or older. "In clinical trials in … |
